Rigorous science demands support of transgender scientists.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 17 01 2024
revised: 09 02 2024
accepted: 20 02 2024
medline: 18 3 2024
pubmed: 16 3 2024
entrez: 15 3 2024
Statut: ppublish

Résumé

To build a just, equitable, and diverse academy, scientists and institutions must address systemic barriers that sex and gender minorities face. This Commentary summarizes (1) critical context informing the contemporary oppression of transgender people, (2) how this shapes extant research on sex and gender, and (3) actions to build an inclusive and rigorous academy for all.

Identifiants

pubmed: 38490174
pii: S0092-8674(24)00187-9
doi: 10.1016/j.cell.2024.02.021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1327-1334

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests A.I.S. received consulting fees from the World Health Organization to conduct systematic reviews on transgender health.

Auteurs

Krisha Aghi (K)

Department of Integrative Biology and Physiology, UCLA, Los Angeles, CA, USA.

Brendan M Anderson (BM)

Paleontological Research Institution, Ithaca, NY, USA.

Bria M Castellano (BM)

Sarafan ChEM-H, Stanford University, Stanford, CA, USA.

Avery Cunningham (A)

College of EPS, University of Birmingham, Birmingham, UK.

Maggie Delano (M)

Department of Engineering, Swarthmore College, Swarthmore, PA, USA.

Evyn S Dickinson (ES)

Department of Neuroscience, Yale University, New Haven, CT, USA.

Lexy von Diezmann (L)

Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN, USA. Electronic address: lvondiez@umn.edu.

Sofia Kirke Forslund-Startceva (SK)

Experimental and Clinical Research Centre, a joint venture of Charité University Hospital and the Max Delbrück Centre, Berlin, Germany.

Dori M Grijseels (DM)

Social Systems and Circuits Group, Max Planck Institute for Brain Research, Frankfurt am Main, Germany.

Sebastian S Groh (SS)

Quality Enhancement Directorate, Cardiff Metropolitan University, Cardiff, UK.

Eartha Mae Guthman (EM)

Princeton Neuroscience Institute, Princeton University, Princeton, NJ, USA; Center for Applied Transgender Studies, Chicago, IL, USA.

Izzy Jayasinghe (I)

School of Biosciences, The University of Sheffield, Sheffield, UK; Department of Molecular Medicine, University of New South Wales, Sydney, Australia.

Juliet Johnston (J)

Civil and Environmental Engineering, Georgia Institute of Technology, Atlanta, GA, USA.

Sam Long (S)

Denver Public Schools, Denver, CO, USA.

Jess F McLaughlin (JF)

Department of Environmental Conservation, University of Massachusetts Amherst, Amherst, MA, USA.

Maeve McLaughlin (M)

Department of Microbiology, Genetics, and Immunology, Michigan State University, East Lansing, MI, USA. Electronic address: mclau204@msu.edu.

Miriam Miyagi (M)

Center for Computational Molecular Biology, Brown University, Providence, RI, USA.

Bittu Rajaraman (B)

Departments of Biology and Psychology, Ashoka University, Sonipat, Haryana, India.

Fátima Sancheznieto (F)

Institute for Clinical and Translational Research, University of Wisconsin-Madison, Madison, WI, USA.

Ayden I Scheim (AI)

Epidemiology and Biostatistics, Drexel University, Philadelphia, PA, USA.

Simón E D Sun (SED)

Center for Applied Transgender Studies, Chicago, IL, USA; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA. Electronic address: sisun@cshl.edu.

F Dylan Titmuss (FD)

Department of Applied Ocean Physics and Engineering, Woods Hole Oceanographic Institution, Woods Hole, MA, USA.

Reubs J Walsh (RJ)

Center for Applied Transgender Studies, Chicago, IL, USA; Department of Psychology, Faculty of Arts & Sciences, University of Toronto, Toronto, ON, Canada.

Zara Y Weinberg (ZY)

Department of Biochemistry & Biophysics, UCSF, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH